UPDATE : Monday, March 19, 2018
Pfizer’s P2 trial for lung cancer drug shows 90% effectiveness
Pfizer presented phase 2 trial data for its investigational lung cancer dru...
by Marian Chu  |  2017-10-17 16:05
GSK’s shingles vaccine gets 1st approval from Canada
The Canadian health regulators Friday approved GlaxoSmithKline (GSK)’s vacc...
by Marian Chu  |  2017-10-17 15:25
‘Austrian companies actively seek partnerships with Korean ones’
The Austrian Embassy in Seoul kicked off its Life Science Forum Tuesday to ...
by Marian Chu  |  2017-10-17 15:23
J&J penalized for advertising Band-Aids on homepage
The Ministry of Food and Drug Safety has barred Johnson & Johnson Korea fro...
by Marian Chu  |  2017-10-16 17:32
Hanmi Science agree with Italian hospital for public health research
Hanmi Science signed a research agreement for public health with Policlinic...
by Lee Han-soo  |  2017-10-16 16:30
Mandatory drug labeling of all ingredients to start in December
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association on Friday...
by Lee Hye-seon  |  2017-10-16 15:33
Sanofi Pasteur to withdraw ID Flu from Korean market
Sanofi Pasteur Korea said Friday that it plans to pull their Intradermal (I...
by Lee Han-soo  |  2017-10-13 17:52
Medytox, Daewoong squabble over US lawsuit
A heated debate is going on between Daewoong Pharmaceuticals and Medytox ov...
by Lee Han-soo  |  2017-10-13 15:43
‘AstraZeneca’s lung cancer drug may not get insurance coverage’
AstraZeneca’s drug Tagrisso (ingredient: osimertinib) for the treatment of ...
by Park Gi-taek  |  2017-10-13 14:02
2 orphan drugs find manufacturers in Korea
Two orphan drugs, Dapsone and Mexiletine, which have been in supply shortag...
by Lee Hye-seon  |  2017-10-12 15:48
Roche Korea’s lung cancer drug increases cost-effectiveness
Roche Korea said Thursday Alecensa (ingredient: alectinib) would get cheape...
by Marian Chu  |  2017-10-12 14:59
Rethink obesity, says Novo Nordisk Korea
Obesity should no longer be seen as the result of individuals’ habits but r...
by Marian Chu  |  2017-10-12 11:20
AstraZeneca’s ovarian cancer drug more affordable
AstraZeneca Korea said Friday its ovarian cancer drug Lynparza began to rec...
by Marian Chu  |  2017-10-11 18:14
Boryung to sell antihypertensive drugs in SE Asia
South Korea’s Boryung Pharmaceutical said it would sell its antihypertensiv...
by Lee Hye-seon  |  2017-10-11 16:02
Daewoong to sell Novartis’ osteoporosis drug
Daewoong pharmaceutical said Wednesday it acquired marketing and commercial...
by Marian Chu  |  2017-10-11 11:39
Green Cross units sign MOU with Sudan Central Lab
Green Cross MS and Green Cross Laboratories have signed a memorandum of und...
by Lee Han-soo  |  2017-10-10 15:53
SK Chemicals ‘Skyzoster’ wins sales approval
SK Chemicals received the sales approval for Skyzoster, a shingles vaccine,...
by Lee Han-soo  |  2017-10-10 12:16
Immunotherapy developers engage in fierce competition to expand indications
Bristol-Myers Squibb and Merck & Co are conducting several clinical trials ...
by Marian Chu  |  2017-10-05 06:00
Dongkook Pharm, Madagascar government to develop natural medicines
Dongkook Pharmaceuticals said Friday that it has signed an agreement with t...
by Lee Han-soo  |  2017-09-29 17:39
AbbVie’s hepatitis C treatment approved in Japan
AbbVie said Thursday that its G/P (glecaprevir/pibrentasivr) treatment, sho...
by Marian Chu  |  2017-09-29 12:03
Back to Top